Molecular Diagnostics: Page 4

Imaware acquires Binx Health’s consumer-testing business
By LabPulse.com staff writers
Molecular diagnostics and consumer testing company Imaware has acquired Binx Health’s at-home consumer testing business for an undisclosed sum.
December 6, 2023
Doctor Lab Test Bipoc Social
UK Biobank shares 500K WGS linked to 15 years of health data
By Nick Paul Taylor
UK Biobank has made deidentified whole genome sequencing (WGS) data on 500,000 people available, enabling researchers around the world to analyze the genomics results alongside 15 years of health data on the individuals.
December 4, 2023
Science Genome Sequence Dna Map Social
KSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapy
By LabPulse.com staff writers
Biotech firm KSQ Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a phase I and II trial of KSQ-001EX, KSQ’s CRISPR-Cas9 engineered tumor-infiltrating lymphocyte program.
November 29, 2023
Crispr Cas9 Gene Editing Social
Nanopore sequencing slashes tumor analysis times and costs
By Nick Paul Taylor
Nanopore sequencing makes the analysis of copy number variations (CNVs) faster, cheaper, and simpler, according to a preprint paper from researchers at Dartmouth-Hitchcock Medical Center.
November 28, 2023
Dna Sequence Social
Bit.bio unveils cell therapy candidate for liver conditions
By Matt Limb
Synthetic biology company bit.bio has unveiled a lead cell therapy candidate as a treatment for life-threatening liver conditions, and it has set out its broader cell therapy pipeline.
November 22, 2023
Liver Anatomy Social
U.K. regulators approve 'world-first' sickle-cell gene therapy
By Matt Limb
U.K. medical regulators have approved a “world-first” gene therapy that aims to cure two blood disorders: sickle cell disease and transfusion-dependent β-thalassemia. They are the first regulatory body to approve the treatment.
November 20, 2023
Sickle Cell Anemia2 Social
Verici DX, Thermo Fisher Scientific sign licensing agreement on pre-transplant prognostic test
By LabPulse.com staff writers
Transplant diagnostic firm Verici DX and Thermo Fisher Scientific have signed an exclusive global licensing and commercialization agreement to develop a pre-transplant prognostic test for early kidney rejection risk assessment.
November 17, 2023
Kidneys Closeup Social
Zymo Research, Ad Astra Diagnostics receive FDA 510(k) clearances
By LabPulse.com staff writers
Molecular diagnostics firm Zymo Research and rapid diagnostics developer Ad Astra Diagnostics have both received 510(k) clearances from the U.S. Food and Drug Administration.
November 16, 2023
Fda Button Social
AnchorDx, DiaCarta to collaborate on cancer diagnostics
By LabPulse.com staff writers
Biotech company AnchorDx has entered into a long-term partnership with molecular diagnostics firm DiaCarta to develop and commercialize cancer diagnostic products for the global market.
November 14, 2023
Hands Shaking Deal Social
Illumina launches pricing program for pathogen sequencing tools in LMICs
By LabPulse.com staff writers
Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).
November 13, 2023
Infectious Diseases Research Social
Pan-cancer study reveals epigenomic drivers for cancer development, progression
By LabPulse.com staff writers
A team of researchers have identified epigenomic drivers associated with cancer development and progression, constructing a pan-cancer epigenetic and transcriptomic atlas from the data.
November 3, 2023
Cancer Cell Microenvironment Social
U.K. trial approved for Hunter syndrome gene therapy
By Matt Limb
U.K. regulators have approved the “first ever” trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a rare lysosomal storage disorder.
November 9, 2023
Gene Therapy Dna Scientist Social
Previous Page
Page 4 of 193
Next Page